Clinical Trials Directory

Trials / Completed

CompletedNCT04964180

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
South Valley University · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Hospitals, Qena, Egypt in period between May 2020 to May 2021.eighty patients was scheduled to elective laparoscopic cholecystectomy , divided Into two groups randomly using closed envelop method. Group IP lidocaine(40 patients ) received 200 ml saline containing 200 mg 2%lidocaine immediately after abdominal cO2 insufflation( pneumoperitoneum) the surgeon sprayed the total solution on the upper surface of the liver under the right subdiaphragmatic space, left subdiaphragmatic space and around the cholecystectomy site , all patients were maintained in trendelenberg position. At the end of the laparoscopic procedure, group indomethacin (40 patients) recived two 100 mg indomethacin rectal suppositories 2 hours prior to surgery

Conditions

Interventions

TypeNameDescription
DRUGIndomethacin suppositorytwo 100 mg indomethacin rectal suppositories 2 hours prior to surgery
DRUGLidocaine 2% Injectable Solution200 ml saline containing 200 mg 2%lidocaine intraperitoneal insilltation

Timeline

Start date
2020-05-01
Primary completion
2021-05-30
Completion
2021-06-20
First posted
2021-07-15
Last updated
2021-07-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04964180. Inclusion in this directory is not an endorsement.